المؤلفون: Andreas Engert, Carsten Kobe, Bernd Hertenstein, Bastian von Tresckow, Max S. Topp, Michael Fuchs, Markus Dietlein, Helen Goergen, Andreas Lohri, Volker Diehl, Josee M. Zijlstra, Julia Meissner, Andreas Rosenwald, Julia Thiemer, Georg Kuhnert, Stephanie Sasse, Peter Borchmann, Georg Maschmeyer, Martin Vogelhuber, Ulrich Dührsen, Stefan W. Krause, Richard Greil, Andreas Viardot, Erhardt Schäfer, Martin Soekler, Christian Baues, Hans Theodor Eich, Martin Wilhelm, Ulrich Keller

المساهمون: CCA - Imaging and biomarkers, CCA - Cancer Treatment and quality of life, Hematology

المصدر: Fuchs, M, Goergen, H, Kobe, C, Kuhnert, G, Lohri, A, Greil, R, Sasse, S, Topp, M S, Schäfer, E, Hertenstein, B, Soekler, M, Vogelhuber, M, Zijlstra, J M, Keller, U B, Krause, S W, Wilhelm, M, Maschmeyer, G, Thiemer, J, Dührsen, U, Meissner, J, Viardot, A, Eich, H, Baues, C, Diehl, V, Rosenwald, A, Von Tresckow, B, Dietlein, M, Borchmann, P & Engert, A 2019, ' Positron emission tomography-guided treatment in early-stage favorable Hodgkin lymphoma : Final results of the international, randomized phase III HD16 trial by the German Hodgkin Study Group ', Journal of Clinical Oncology, vol. 37, no. 31, pp. 2835-2845 . https://doi.org/10.1200/JCO.19.00964Test
Journal of Clinical Oncology, 37(31), 2835-2845. American Society of Clinical Oncology

مصطلحات موضوعية: Cancer Research, medicine.medical_specialty, medicine.diagnostic_test, business.industry, medicine.medical_treatment, Dacarbazine, Medizin, Bleomycin, Vinblastine, law.invention, Radiation therapy, chemistry.chemical_compound, Oncology, chemistry, ABVD, Randomized controlled trial, Positron emission tomography, law, medicine, Radiology, Progression-free survival, business, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aaa469fe12172ec2dda9ea09d53492d2Test
https://research.vumc.nl/en/publications/79c66fe8-a87f-4981-8d5b-ffffc8af5736Test

المؤلفون: Martin Vogelhuber, Boris Böll, Martin Sökler, Michael Pfreundschuh, Peter Borchmann, Michael Fuchs, Indra Thielen, Carolin Bürkle, Bastian von Tresckow, Dennis A. Eichenauer, Annette Plütschow, Michaela Feuring-Buske, Andreas Engert, Johannes Atta

المصدر: British journal of haematology. 185(1)

مصطلحات موضوعية: Oncology, Male, medicine.medical_specialty, Dacarbazine, Bleomycin, Vinblastine, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, Interquartile range, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, medicine, Humans, Doxorubicin, Lenalidomide, Aged, Neoplasm Staging, Geriatrics, business.industry, Age Factors, Hematology, Middle Aged, Prognosis, Hodgkin Disease, Treatment Outcome, ABVD, chemistry, 030220 oncology & carcinogenesis, Female, business, 030215 immunology, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aeacb1f1259b2f1a20216c4b6be9c35aTest
https://pubmed.ncbi.nlm.nih.gov/30592027Test

المؤلفون: Bastian von Tresckow, Dennis A. Eichenauer, Jeff Szer, Anna Sureda, Franck Morschhauser, Andreas Engert, Jeremy S. Abramson

المصدر: Leukemia & Lymphoma. 58:222-225

مصطلحات موضوعية: Oncology, Cancer Research, medicine.medical_specialty, medicine.medical_treatment, Hematopoietic stem cell transplantation, Neutropenia, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, immune system diseases, hemic and lymphatic diseases, Internal medicine, Panobinostat, medicine, Chemotherapy, business.industry, Hematology, medicine.disease, Discontinuation, Transplantation, Clinical trial, chemistry, 030220 oncology & carcinogenesis, Immunology, Stem cell, business, 030215 immunology

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::43a1bc0d2768cb6046de3b49c737947cTest
https://doi.org/10.1080/10428194.2016.1182164Test

المؤلفون: Andrea Kerkhoff, Peter Borchmann, Bastian von Tresckow, Felicitas Hitz, Paul J Bröckelmann, Karolin Behringer, Richard Greil, Sven Borchmann, Carolin Bürkle, Andreas Engert, Helen Goergen, Michael Fuchs, Dennis A. Eichenauer, Volker Diehl, Boris Böll

المصدر: Blood. 127:2189-2192

مصطلحات موضوعية: Adult, Lung Diseases, Male, medicine.medical_specialty, Pulmonary toxicity, Dacarbazine, medicine.medical_treatment, Immunology, Kaplan-Meier Estimate, Vinblastine, Bleomycin, Biochemistry, Gastroenterology, Disease-Free Survival, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, Humans, Medicine, Adverse effect, Aged, Neoplasm Staging, Chemotherapy, Dose-Response Relationship, Drug, business.industry, Remission Induction, Age Factors, Cell Biology, Hematology, Middle Aged, Hodgkin Disease, Chemotherapy regimen, Surgery, chemistry, ABVD, Doxorubicin, 030220 oncology & carcinogenesis, Female, business, 030215 immunology, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fc788581949a2503fd80dd2ea227e7c0Test
https://doi.org/10.1182/blood-2015-11-681064Test

المؤلفون: John M. M. Raemaekers, Bastian von Tresckow, Oliver Schmalz, Lenka Šmardová, Peter Borchmann, Bernd Metzner, Hartmut Doehner, Kerstin Schäfer-Eckart, Norbert Schmitz, Andreas Engert, Horst Müller, Dietger Niederwieser, Stephanie Sasse, Magdalena Alram, Thomas Fischer

المصدر: Leukemia & Lymphoma, 57, 1067-73
Leukemia & Lymphoma, 57, 5, pp. 1067-73

مصطلحات موضوعية: Oncology, BEACOPP, Adult, Male, Cancer Research, medicine.medical_specialty, medicine.medical_treatment, Salvage therapy, Hematopoietic stem cell transplantation, Dexamethasone, 03 medical and health sciences, 0302 clinical medicine, Recurrence, Internal medicine, DHAP, Germany, Antineoplastic Combined Chemotherapy Protocols, medicine, Humans, Neoplasm Staging, Proportional Hazards Models, Salvage Therapy, business.industry, Cytarabine, Hematopoietic Stem Cell Transplantation, Induction chemotherapy, Hematology, Middle Aged, Prognosis, Combined Modality Therapy, Hodgkin Disease, 3. Good health, Surgery, Treatment Outcome, ABVD, 030220 oncology & carcinogenesis, Retreatment, Female, Radiotherapy, Adjuvant, Cisplatin, business, Chemoradiotherapy, Rare cancers Radboud Institute for Health Sciences [Radboudumc 9], 030215 immunology, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2e8181568ad1164a7109220f0a65bf33Test
https://hdl.handle.net/2066/171275Test

المؤلفون: Dennis A. Eichenauer, Peter Borchmann, Bastian von Tresckow, Hans Theodor Eich, Michael Fuchs, Andreas Engert, Karolin Behringer, Annette Plütschow, Volker Diehl, Boris Böll

المصدر: Journal of Clinical Oncology. 33:2857-2862

مصطلحات موضوعية: Adult, Male, Cancer Research, medicine.medical_specialty, Adolescent, medicine.medical_treatment, Gastroenterology, Recurrence, Internal medicine, medicine, Humans, Patient group, Stage (cooking), Aged, Neoplasm Staging, business.industry, Optimal treatment, Neoplasms, Second Primary, Middle Aged, Combined Modality Therapy, Hodgkin Disease, Surgery, Clinical trial, Radiation therapy, Oncology, Nodular Lymphocyte Predominant Hodgkin Lymphoma, Hodgkin lymphoma, Female, Rituximab, business, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2c8bce6d67b2fdfbd9f676500557df44Test
https://doi.org/10.1200/jco.2014.60.4363Test

المؤلفون: Martin Sökler, Ulrich Keller, Carsten Kobe, Bastian von Tresckow, Andreas Rosenwald, Stephan Mathas, Paul J Bröckelmann, Michael Fuchs, Jasmin Mettler, Julia Meissner, Peter Borchmann, Andrea Kerkhoff, Andreas Zimmermann, Stephanie Sasse, Wolfram Klapper, Helen Goergen, Rainer Ordemann, Andreas Engert, Matthias Bormann, Teresa V Halbsguth, Christian Baues, Andreas Hüttmann

المصدر: JAMA Oncol

مصطلحات موضوعية: Adult, Male, Cancer Research, medicine.medical_specialty, Adolescent, Dacarbazine, Programmed Cell Death 1 Receptor, Medizin, Vinblastine, law.invention, Young Adult, 03 medical and health sciences, Antineoplastic Agents, Immunological, 0302 clinical medicine, Randomized controlled trial, law, Germany, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, Concomitant Therapy, Clinical endpoint, Humans, Medicine, 030212 general & internal medicine, Progression-free survival, Immune Checkpoint Inhibitors, Original Investigation, business.industry, Remission Induction, Middle Aged, Hodgkin Disease, Progression-Free Survival, Clinical trial, Nivolumab, Oncology, Doxorubicin, 030220 oncology & carcinogenesis, Concomitant, Female, business, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::15e34c1aef03ff118d1ea9a9559dc418Test
https://doi.org/10.1001/jamaoncol.2020.0750Test

المؤلفون: Alex F. Herrera, Bastian von Tresckow, Pauline Brice, Daniel Molin, Nathalie A. Johnson, Craig H. Moskowitz, Pier Luigi Zinzani, Margaret A. Shipp, Akihiro Tomita, Vincent Ribrag, Jianxin Lin, John Radford, Hun Ju Lee, Theodoros P. Vassilakopoulos, Philippe Armand, Eunhee Kim, Mohammed Z.H. Farooqui, Patricia Marinello

المصدر: Blood. 134:240-240

مصطلحات موضوعية: 0301 basic medicine, Oncology, medicine.medical_specialty, Chlorambucil, business.industry, Immunology, Cell Biology, Hematology, Pembrolizumab, Neutropenia, medicine.disease, Biochemistry, Chemotherapy regimen, Lymphoma, 03 medical and health sciences, 030104 developmental biology, 0302 clinical medicine, 030220 oncology & carcinogenesis, Internal medicine, Relapsed refractory, medicine, Hodgkin lymphoma, Brentuximab vedotin, business, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::819e4122e413c9c071ed8842a1cb299cTest
https://doi.org/10.1182/blood-2019-127280Test

المؤلفون: Julia Meissner, Jana Markova, Josée M. Zijlstra, Annette Plütschow, Andreas Engert, Max S. Topp, Peter Borchmann, Richard Greil, Volker Diehl, Dennis A. Eichenauer, Bastian von Tresckow, Michael Fuchs, Sarah Gillessen

المصدر: Blood. 134:129-129

مصطلحات موضوعية: medicine.medical_specialty, Long term follow up, business.industry, Immunology, Cell Biology, Hematology, Interim analysis, Biochemistry, Cancer recurrence, Treatment failure, Regimen, Internal medicine, medicine, Clinical endpoint, Early Unfavorable Hodgkin Lymphoma, Dose intensification, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::4b24814a079e8ae440b5654cc2d3818fTest
https://doi.org/10.1182/blood-2019-125249Test

المؤلفون: Stephan Mathas, Carsten Kobe, Julia Meissner, Andreas Zimmermann, Andreas Hüttmann, Peter Borchmann, Christian Baues, Paul J Bröckelmann, Andreas Rosenwald, Helen Goergen, Andrea Kerkhoff, Matthias Bormann, Wolfram Klapper, Rainer Ordemann, Andreas Engert, Teresa V Halbsguth, Bastian von Tresckow, Michael Fuchs, Stephanie Sasse, Martin Sökler, Ulrich Keller

المصدر: Blood. 134:236-236

مصطلحات موضوعية: 0301 basic medicine, medicine.medical_specialty, Surrogate endpoint, business.industry, Dacarbazine, Immunology, Medizin, Cell Biology, Hematology, medicine.disease, Biochemistry, Discontinuation, 03 medical and health sciences, 030104 developmental biology, 0302 clinical medicine, Chemoimmunotherapy, Internal medicine, Concomitant, medicine, Clinical endpoint, Nivolumab, business, Progressive disease, 030215 immunology, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a738656b819097b092e4e053d8ddfee2Test
https://doi.org/10.1182/blood-2019-122406Test